Sachdev Sidhu, PhD
Co-founder & Board Member
Dev Sidhu is a Professor at the Anvil Institute, University of Waterloo. Dr. Sidhu served as a professor at the Donnelly Centre for Cellular & Biomolecular Research during 2008-2022. Prior to this, he was a Principal Investigator in the Department of Protein Engineering at Genentech. He returned to academia after a distinguished career at Genentech for abut 10 years period where he led the development of its phage display technology. Dr. Sidhu’s research is primarily focused in the field of protein engineering and technologies that explore and shape protein and antibody structure and function, with the aim of crafting better therapies for cancer and other diseases. He has a wealth of experience in commercial antibody discovery. He has published more than 200 scientific papers and is a co-inventor on more than 50 patents granted or filed with the US patent office. Dr. Sidhu was the recipient of the 2015 Christian B. Anfinsen Award of the Protein Society for significant technological achievements in protein research. Multiple therapeutic companies have been created from the antibodies generated by Dev and his team, including Pionyr, AntlerA, Aarvik and others.
Statement: Aarvik appreciates the support of our mentors, families, and colleagues, which has laid a strong foundation for our success.